The RAG cell line defines a new complementation group of MHC class II deficiency

Immunogenetics

Volumn 43, Issue 6, 1996, Pages 352-359

  Lennon, Ana Maria ^a   Ottone, Catherine ^a   Peijnenburg, Ad ^b   Hamon Benais, Chantal ^a   Colland, Frédéric ^a   Gobin, Sam ^b   Van Den Elsen, Peter ^b   Fellous, Marc ^a   Bono, Rosa ^c   Alcaïde Loridan, Catherine ^a  

^a INSTITUT PASTEUR   (France)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL FUSION; CELL LINE; CHROMOSOME 16; CONTROLLED STUDY; DNA TRANSFECTION; GENE INDUCTION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HYBRID CELL; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 9044237265     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02199803     Document Type: Article

References (42)

1. Bénichou, B. and Strominger, J. L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 88: 4285-4288, 1991
2. Bono, R., Hyafil, F., Kalil, J., Koblar, V., Wiels, J., Wollman, E., and Fellous, M. Monoclonal antibodies against HLA-DRw antigens. Transplant Clin Immunol XI: 109-117, 1979
3. Bono, M. R., Benech, P., Couillin, P., Alcaïde-Loridan, C., Grisard, M.-C., Jouin, H., Fischer, D. G., and Fellous, M. Characterization of human IFN-γ response using somatic cell hybrids of hematopoietic and nonhematopoietic origin. Somat Cell Mol Genet 15: 513-523, 1989
4. Bono, M. R., Alcaïde-Loridan, C., Couillin, P., Letouzé, B., Grisard, M.-C., Jouin, H., and Fellous, M. Human chromosome 16 encodes a factor involved in induction of class II major histocompatibility antigens by interferon γ. Proc Natl Acad Sci USA 88: 6077-6081, 1991a
5. Bono, M. R., Alcaïde-Loridan, C., Letouzé, B., Jouin, H., Gobin, S. J. P., and Fellous, M. The recombinant human interferon-γ receptor is fully functional in a human × murine hybrid containing human chromosome 21. Res Immunol 142: 765-772, 1991b
6. Boss, J. M. and Strominger, J. L. Regulation of transfected human class II major histocompatibility complex gene in human fibroblasts. Proc Natl Acad Sci USA 83: 9139-9143, 1986
7. Chang, C. H. and Flavell, R. A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 181: 765-767, 1995
8. Chen, C. and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745-2752, 1987
9. Chin, K.-C., Mao, C., Skinner, C., Riley, J. L., Wright, K. L., Moreno, C. S., Stark, G. R., Boss, J. M., and Ting, J. P.-Y. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in class II MHC and Ii gene induction. Immunity 1: 687-697, 1994
10. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically-active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979
11. Couillin, P., Mollicone, R., Grisard, M.-C., Gibaud, A., Ravisé, N., Feingold, J., and Oriol, R. Chromosome 11q localization of one of the three expected genes for the human alpha-3-fucosyltransferases by somatic hybridization. Cytogenet Cell Genet 56: 108-111, 1991
12. Darnell, J. E., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421, 1994
13. DePréval, C., Lisowska-Grospierre, B., Loche, M., Griscelli, C., and Mach, B. A trans-acting class II regulatory gene unlinked to the MHC controls the expression of HLA class II genes. Nature 318: 291-293, 1985
14. Dorn, A., Durand, B., Marfing, C., LeMeur, M., Benoist, C., and Mathis, D. Conserved major histocompatibility complex class II boxes-X and -Y are transcriptional control elements and specifically bind nuclear proteins. Proc Natl Acad Sci USA 84: 6249-6253, 1987
15. Durand, B., Kobr, M., Reith, W., and Mach, B. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol Cell Biol 14: 6839-6848, 1994
16. Fling, S. P., Arp, B., and Pious, D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368: 554-558, 1994
17. Germain, R. N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-299, 1994
18. Gladstone, P. and Pious, D. Stable variants affecting B cell alloantigens in human lymphoid cells. Nature 27: 459-461, 1978
19. Glimcher, L. H., and Kara, C. J. Sequences and factors: a guide to MHC class II transcription. Annu Rev Immunol 10: 13-50, 1992
20. Graham, F. L. and Van den Eb, A. J. A new technique for the assay of infectivity of adenovirus 5 DNA. Virology 52: 456-467, 1973
21. Greenlund, A. C., Farrar, M. A., Viviano, B., and Schreiber, R. D. Ligand-induced IFN-γ receptor tyrosine phosphorylation couples the receptor to its signal transduction system. EMBO J 13: 1591-1600, 1994
22. Hume, C. R. and Lee, J. S. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes results from distinct mutations in trans-acting factors. Hum Immunol 26: 288-309, 1989
23. Igarashi, K., Garotta, G., Ozmen, L., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Larner, A. C., and Finbloom, D. S. Interferon-γ induces phosphorylation of interferon-γ receptor and regulated association of protein tyrosine kinases, Jak-1 and Jak-2, with its receptor. J Biol Chem 269: 14333-14336, 1994
24. Kappler, J. W., Skidmore, B., White, J., and Marrack, P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. J Exp Med 153: 1198-1214, 1981
25. Kelly, A. P., Monaco, J. J., Cho, S., and Trowsdale, J. A new human HLA class II-related locus, DM. Nature 353: 571-573, 1991
26. Koch, W., Benoist, C., and Mathis, M. Anatomy of a new B-cell-specific enhancer. Mol Cell Biol 9: 303-311, 1989
27. Lambert, M., VanEggermond, M., Verheij, C., VanRee, J., and Van Den Elsen, P. J. Analysis of MHC class II transcription in two bare lymphocyte syndrome patients of a single family. Immunodeficiency 4: 277-284, 1993
28. Lisowska-Grospierre, B., Fondaneche, M.-C., Rois, M.-P., Griscelli, C., and Fischer, A. Two complementation groups account for most cases in inherited MHC class II deficiency. Hum Molec Gene 3: 953-958, 1994
29. Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., Pellegrini, S., Wilks, A. F., Ihle, J. N., Stark, G. R., and Kerr, I. M. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366: 129-135, 1993a
30. Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., and Kerr, I. M. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J 12: 4221-4228, 1993b
31. O'Sullivan, D. M., Larhammar, D., Wilson, M. C., and Peterson, P. A. Structure of the human Ia-associated invariant (γ)-chain gene: identification of 5′ sequences shared with major histocompatibility complex class II genes. Proc Natl Acad Sci USA 83: 4484-4488, 1986
32. Peijnenburg, A., Godthelp, B., Van Boxel-Dezaire, A., and Van den Elsen, P. J. Definition of a novel group in MHC class II deficiency. Immunogenetics 41: 287-294, 1995
33. Riley, J. L., Westerheide, S. D., Price, J. A., Brown, J. A., and Boss, J. M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2: 533-543, 1995
34. Shuai, K., Schindler, C., Prezioso, V. R., and Darnell, J. E. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258: 1808-1812, 1992
35. Sloan, V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D. M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802-806, 1995
36. Southern, P. J. and Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1: 327-341, 1982
37. Steimle, V., Otten, L. A., Zufferey, M., and Mach, B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell 75: 135-146, 1993
38. Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator CIITA. Science 265: 106-109, 1994
39. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., and Reith, W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9: 1021-1032, 1995
40. Strubin, M., Mach, B., and Long, E. O. The complete sequence of the mRNA for the HLA-DR-associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. EMBO J 3: 869-872, 1984
41. Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C., Schindler, C., Stark, G. R., Ihle, J. N., and Kerr, I. M. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 366: 166-170, 1993
42. Zhou, H. and Glimcher, L. H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2: 545-553, 1995